Product image of Mometason Aristo Heuschnupfenspray (Mometasone Furoate Ph. Eur.) supplied by GNH India

Mometason Aristo Heuschnupfenspray

Active Ingredient:
Mometasone Furoate Ph. Eur.
Origin:
EU

Mometason Aristo Heuschnupfenspray (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Mometason Aristo Heuschnupfenspray, is a glucocorticoid presented as a nasal spray for nasal use. It treats allergic rhinitis and seasonal nasal allergy in adults and children.

GNH India supplies Mometason Aristo Heuschnupfenspray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aristo Pharma Gmbh (Art 57)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal passages associated with allergic rhinitis.
  • Allergic rhinitis: reduces nasal congestion, itching, and sneezing.
  • Seasonal nasal allergy: provides symptom relief during pollen or other seasonal allergen exposure.
  • Hay fever: controls nasal symptoms during hay‑fever episodes.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors in nasal mucosal cells, altering gene transcription. This down‑regulates pro‑inflammatory cytokines, chemokines, and adhesion molecules, leading to reduced vascular permeability, edema, and inflammatory cell infiltration, thereby decreasing nasal inflammation and symptom severity.

Side Effects

Adverse reactions may occur with nasal administration of mometasone furoate.

Common Side Effects

  • Nasal irritation or burning sensation.
  • Headache.
  • Epistaxis (nosebleed).
  • Throat irritation or dryness.
  • Cough.
  • Altered taste or bitter taste.

Serious or Rare Side Effects

  • Nasal septal perforation.
  • Severe allergic reaction (anaphylaxis).
  • Vision changes or increased intra‑ocular pressure.
  • Systemic corticosteroid effects such as adrenal suppression.
  • Fungal infection of the nasal passages.
  • Persistent nasal dryness leading to crusting.

Precautions & Warnings

  • Before using Mometason Aristo Heuschnupfenspray, consider the following safety measures.
  • Pregnancy: consult a healthcare provider before use.
  • Breastfeeding: discuss potential risks with a physician.
  • Nasal infection: avoid use if an active infection of the nasal passages is present.
  • Long‑term therapy: monitor for signs of nasal mucosal atrophy or septal perforation.
  • Pediatric use: follow pediatric dosing guidance and monitor growth.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Mometasone furoate nasal spray may interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid)

  • Systemic corticosteroids: increased risk of systemic glucocorticoid effects.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure.
  • Live nasal vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., itraconazole): may increase mometasone levels.
  • Ritonavir or other protease inhibitors: may elevate exposure.
  • St. John's wort or other CYP3A4 inducers: may reduce therapeutic effect.

Frequently Asked Questions

Mometason Aristo Heuschnupfenspray is a nasal spray containing mometasone furoate, indicated for the relief of symptoms associated with allergic rhinitis and seasonal nasal allergies such as congestion, itching, sneezing, and runny nose.

Mometasone furoate binds to glucocorticoid receptors in the cells of the nasal mucosa, modulating gene transcription to suppress the release of inflammatory mediators. This reduces swelling, mucus production, and the overall inflammatory response in the nasal passages.

The prescribed dose of Mometason Aristo Heuschnupfenspray is determined by a qualified healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mometasone furoate is a high‑potency, once‑daily nasal corticosteroid with a favorable safety profile when used as directed. Compared with lower‑potency options, it often provides effective symptom control with a lower total dose, but choice of therapy should be individualized by the prescriber.

Store the spray at room temperature, preferably below 25 °C, in its original packaging. Protect it from excessive moisture and direct sunlight. Keep the device upright and avoid freezing the product.

The spray is administered intranasally. The patient gently shakes the bottle, primes it if required, tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, systemic corticosteroid effects like adrenal suppression, and ocular complications such as increased intra‑ocular pressure or cataract formation. Patients should seek immediate medical attention if these occur.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid use. It is also contraindicated in patients with active untreated nasal infections, recent nasal surgery, or those who have experienced severe reactions to other nasal corticosteroids.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate Ph. Eur.

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT